Last updated on March 1st, 2018
Radioactive iodine (primarily I-131) is a waste product of nuclear fission produced in nuclear reactors and nuclear bombs.
In the event of such a nuclear catastrophe, and what makes I-131 so dangerous, is that the body cannot distinguish I-131 from ordinary iodine.
As a result, if it’s inhaled or swallowed following a nuclear ‘event’, it will be absorbed into the thyroid gland and will poison its victim.
Depending on the absorption, the effects can lead to thyroid damage, cancer, growth and birth defects, or even death.
The good news is that there’s an easy way to block it, and something that I believe everyone should have as part of their preparedness or survival kit. This is especially significant if living near or downwind from a nuclear power plant or if concerned about their proximity to a potential nuclear detonation…
iOSAT ™ [potassium iodide] Nuclear Protection
It protects against radioactive iodine by preventing absorption into the thyroid gland. It does this by saturating the thyroid with stable iodine, “filling it to capacity”. Once filled, the gland “turns off” its absorption mechanism, and it will remain off long enough for the radioactive iodine to disappear naturally.
This method of protection is extremely safe and effective, and up to 99% of all radiation induced thyroid damage can be avoided by the use of iOSAT ™.
Because of the inherent safety, the FDA allows iOSAT ™ to be sold without a prescription for radiation protection. Its use, however, should be limited to radiation emergencies, and only when recommended by emergency response authorities.
Note: People should not take iOSAT ™ who have a specific allergy to iodide.
iOSAT ™ is manufactured in the United States under strict FDA “GMP guidelines,” and holds an approved “New Drug Application” (NDA).
iOSAT ™ is the only product which can be purchased by local, state and federal governments and is widely purchased by nuclear utilities.
iOSAT ™ comes full strength (130 mg of potassium iodide per tablet) in accordance with FDA demands for complete thyroid blocking.
The daily dosage under new FDA guidelines call for the daily administration of one iOSAT tablet (130 mg. of potassium iodide (KI)) for adults and children over 18 years old who weigh more that 150 pounds.
Children from age 3 to 18 years old who weigh less than 150 pounds should take ½ tablet.
Children from age one month to 3 years should take ¼ tablet.
If necessary, children too young to take solid food or unable to swallow a tablet can take iOSAT ™ dissolved in a liquid (such as chocolate milk) or in a soft food such as applesauce.
iOSAT ™ tablets (shelf life) are FDA approved for seven years and should be stored unopened in a dry environment at room temperature.